Cargando…

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis

BACKGROUND: Randomised controlled trials (RCTs) have reported inconsistent effects from intensified anticoagulation on clinical outcomes in Covid-19. We performed an aggregate data meta-analysis from available trials to quantify effect on non-fatal and fatal outcomes and identify subgroups who may b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wills, Nicola K, Nair, Nikhil, Patel, Kashyap, Sikder, Omaike, Adriaanse, Marguerite, Eikelboom, John, Wasserman, Sean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923119/ https://www.ncbi.nlm.nih.gov/pubmed/35291298 http://dx.doi.org/10.1101/2022.03.05.22271947

Ejemplares similares

Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

Efficacy and Safety of Intensified vs Standard Prophylactic Anticoagulation Therapy in Patients Hospitalized With Coronavirus Disease 2019: Updated Systematic Review and Meta-analysis
por: Scheier, Thomas C, et al.
Publicado: (2023)

Venous Thromboembolism in Patients with Human Immunodeficiency Virus
por: Patel, Kashyap, et al.
Publicado: (2023)

Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis
por: Hariharan, Nikhil Nair, et al.
Publicado: (2022)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
por: Kuno, Toshiki, et al.
Publicado: (2021)

STANDARD VS HIGH-INTENSITY PROPHYLACTIC ANTICOAGULATION IN COVID-19: A US, CALIFORNIAN RETROSPECTIVE STUDY
por: AHMADI, TAMANA, et al.
Publicado: (2021)

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
por: Motta, Jishu Kaul, et al.
Publicado: (2020)

Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital‐admitted COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Rauniyar, Robin, et al.
Publicado: (2022)

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
por: Bikdeli, Behnood, et al.
Publicado: (2020)

EFFICACY AND SAFETY OF THERAPEUTIC VERSUS PROPHYLACTIC ANTICOAGULATION IN PATIENTS WITH COVID-19 INFECTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
por: FAIZAN, UNAIZA, et al.
Publicado: (2022)

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2022)

Prophylactic anticoagulation for patients in hospital with covid-19
Publicado: (2021)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

A randomized controlled trial of standard versus intensified tuberculosis diagnostics on treatment decisions by physicians in Northern Tanzania
por: Reddy, Elizabeth A, et al.
Publicado: (2014)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
por: Lee, Hyeon-Jeong, et al.
Publicado: (2023)

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019)

A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome
por: Lin, Raymond, et al.
Publicado: (2019)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19
por: Chambers, Isaac, et al.
Publicado: (2020)

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial
por: Labbe, Vincent, et al.
Publicado: (2022)

Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCT
por: Xuan, Li, et al.
Publicado: (2016)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Unmet Needs in Anticoagulant Therapy: Potential Role of Rivaroxaban
por: Eikelboom, John W., et al.
Publicado: (2015)

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2020)

A randomized study of intensified antiretroviral treatment monitoring versus standard-of-care for prevention of drug resistance and antiretroviral treatment switch
por: Hermans, Lucas E., et al.
Publicado: (2022)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
por: Zhang, Sirui, et al.
Publicado: (2021)

Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation
por: Boonyasai, Romsai T., et al.
Publicado: (2020)

Fatal retroperitoneal hematoma associated with Covid-19 prophylactic anticoagulation protocol
por: Teta, Michael, et al.
Publicado: (2021)

The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2020)

The impact of different prophylactic anticoagulation doses on the outcomes of patients with COVID-19
por: Jiménez-Soto, Rodolfo, et al.
Publicado: (2021)

Value of intensified nursing
por: Frank, Wilhelm, et al.
Publicado: (2006)

Seminar on image intensifiers
por: Klein, Myron W, et al.
Publicado: (1974)

Intensifying vaccine production
Publicado: (2020)

Prophylactic Effects of Propranolol versus the Standard Therapy on a New Model of Disuse Osteoporosis in Rats
por: Khajuria, Deepak Kumar, et al.
Publicado: (2014)

Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study
por: Smadja, David M., et al.
Publicado: (2021)

The Hannover Dialysis Outcome (HAN-D-OUT) study: comparison of standard versus intensified dialysis in treatment of patients with acute kidney injury in the ICU
por: Faulhaber-Walter, R, et al.
Publicado: (2008)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_ffjc94k9fu7jlgbdbesnf76p5f